Skip to main content
Erschienen in: BMC Infectious Diseases 1/2021

Open Access 01.12.2021 | Case report

First case report of acute cholangitis secondary to Cronobacter sakazakii

verfasst von: Syeda Sahra, Abdullah Jahangir, Neville Mobarakai, Allison Glaser, Ahmad Jahangir, Muhammad Ans Sharif

Erschienen in: BMC Infectious Diseases | Ausgabe 1/2021

Abstract

Introduction

Cronobacter sakazakii is an opportunistic Gram-negative, rod-shaped bacterium which may be a causative agent of meningitis in premature infants and enterocolitis and bacteremia in neonates and adults. While there have been multiple cases of C. sakazakii infections, there have been no acute cholangitis cases reported in humans.

Case presentation

An 81-year-old male with a past medical history of basal cell carcinoma, alcoholic liver cirrhosis, transjugular intrahepatic portosystemic shunt procedure, complicated by staphylococcus bacteremia, pituitary tumor, glaucoma, and hypothyroidism presented to the emergency room with the complaint of diffuse and generalized 10/10 abdominal pain of 1 day’s duration. There was a concern for pancreatitis, acute cholangitis, and possible cholecystitis, and the patient underwent a percutaneous cholecystostomy tube placement. Blood cultures from admission and biliary fluid cultures both grew C. sakazakii. The patient was treated with a carbapenem and clinically improved.

Conclusions

The case study described a patient with multiple medical comorbidities that presented with C. sakazakii bacteremia and cholangitis. While this bacterium has been implicated in other infections, we believe this is the first time the bacteria is being documented to have caused acute cholangitis.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
E.R.
Emergency room
MALDI-TOF MS
Matrix-assisted laser desorption ionization-time of flight mass spectrometry

Background

C. sakazakii is responsible for life-threatening infections, including meningitis and brain abscesses with potentially permanent neurological sequelae for the neonatal population. The CC4 variant of Cronobacter has been associated with necrotizing enterocolitis as well. Urinary tract infections, septicemia, and lung and wound infections are reported in adults, particularly in those with underlying immunocompromising comorbidities. We present the first case of acute cholangitis in an elderly male where C. sakazakii was reported on the PCR assay of cultures from blood and biliary fluid. This is the first case of C. sakazakii in the medical literature where it caused cholangitis in an adult patient to the best of our knowledge. The patient responded well to therapy with a carbapenem. Infection with C. sakazakii should be considered in cholangitis in the elderly population with comorbidities not responsive to cephalosporins.

Case presentation

An 81-year-old male came to E.R. with the complaint of abdominal pain of 1 day’s duration. His past medical records were significant for basal cell carcinoma, alcoholic liver cirrhosis with a history of an intrahepatic portosystemic shunt procedure, complicated by staphylococcus bacteremia, pituitary tumor, glaucoma, and hypothyroidism. The abdominal pain had been constant, non-radiating, diffuse, burning in nature, 10/10 in intensity, and associated with chills. He denied any associated fevers, cough, nausea, vomiting, diarrhea, chest pain, headaches, shortness of breath, recent travels, or sick contacts.
On physical examination, his temperature was 98 °F, pulse 104 bpm, blood pressure 133/74 mmHg, respiratory rate 18 beats per minute, O2 saturation 99%. An abdominal exam revealed an obese body habitus, distention, and periumbilical tenderness with a negative Murphy’s sign.
Initial blood work showed normal leukocyte count white blood cells (WBC) 4.5 K/uL, Creatinine 1.2 mg/dL, elevated aspartate aminotransferase (A.S.T.) 62 U/L, elevated Lipase 451 u/L, elevated Lactate 8.8 mmol/L, and normal serum levels of alanine aminotransferase (A.L.T.) 28 U/L, Alkaline Phosphatase 99 U/L, and total serum bilirubin 1.1 mg/dL. The sonogram and C.T. scan of the abdomen revealed perihepatic ascites, nodular liver contour, cholelithiasis, and gallbladder sludge with mild gallbladder wall thickening up to 4 mm without any radiographic evidence of acute cholecystitis (Figs. 1 and 2).
The patient was not a surgical candidate due to his advanced age and multiple comorbidities, and a CT-guided percutaneous cholecystotomy was performed for drainage of biliary fluid by Interventional Radiology. The biliary fluid was sent for culture, and cefepime and metronidazole were started empirically.
On the second day of hospitalization, the periumbilical pain improved, but right upper quadrant tenderness increased, and Murphy’s sign was elicited. The patient concurrently developed fever, leukocytosis (16.5 k/uL) with predominant neutrophilia (81%), and worsening acute kidney injury. Blood specimens drawn on admission were positive for gram-negative rods, which speciated to C. sakazakii on PCR studies. The PCR assay was performed using BioFire FilmArray.
Body fluid samples underwent protein extraction, priming, and drying before matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF) mass spectrometry was applied to the resultant intact cells and extracts from cells. Identification targets other than C. sakazakii were Enterococcus including vancomycin-resistant Enterococcus, L. monocytogenes, coagulase-negative Staphylococcus, S. aureus, S. agalactiae (Group B), S. pneumoniae, S. pyogenes (Group A), A. baumannii, E. cloacae, E. coli, K. oxytoca, K. pneumoniae, Proteus sp., S. marcescens, H. influenzae, N. meningitidis, P. aeruginosa, C. albicans, C. glabrata, C. krusei, C. parapsilosis, C. tropicalis and the K. pneumoniae carbapenemase (KPC) resistant gene. Microflex L.T. and MADLI Biotyper by Bruker Daltonics, Germany was employed in our institutional laboratory for mass spectrometry measurements and microorganism identification. The same organism was found in the biliary drain culture, confirming acute cholangitis due to C. sakazakii complicated by bacteremia. Susceptibilities of C. sakazakii were obtained against 17 antibiotics (Figs. 3 and 4).
Antibiotic coverage was consequently expanded to IV meropenem. His clinical picture and blood work improved exponentially with a downtrend of leukocytes, lactate, lipase, bilirubin, and liver enzymes (Table 1). He was discharged home on hospital day seven on oral ciprofloxacin and metronidazole for 10 days and was reported doing well on telephonic follow-up. The patient was later seen in outpatient clinics (Surgery and Infectious diseases) 2 weeks later. He was asymptomatic without any residual disease, and the biliary drain was removed successfully. The patient underwent an elective cholecystectomy a few weeks later with no complications.
Table 1
Trend of pertinent blood work through the hospitalization
Blood work
Day 1
Day 2
Day 3
Day 4
Discharge blood work
WBC count (k/uL)
4.46
16.59 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figa_HTML.gif
13.62 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figb_HTML.gif
10.59
5.11
Hemoglobin (g/dL)
13.5
12.1
11.1
10.9
11.2
Creatinine (mg/dL)
1.2
1.8 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figc_HTML.gif
1.3 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figd_HTML.gif
1.0
0.9
BUN (mg/dL)
16
38 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Fige_HTML.gif
36 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figf_HTML.gif
29 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figg_HTML.gif
14
Bilirubin Total, serum (mg/dL)
1.1
2.5 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figh_HTML.gif
2.3 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figi_HTML.gif
1.3
1.2
AST (U/L)
62 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figj_HTML.gif
181 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figk_HTML.gif
250 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figl_HTML.gif
170 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figm_HTML.gif
40
ALT (U/L)
28
49
81 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Fign_HTML.gif
67 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figo_HTML.gif
31
Lactate (mmol/L)
8.8 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figp_HTML.gif https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figq_HTML.gif
7.2 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figr_HTML.gif
5 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figs_HTML.gif
4.3 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figt_HTML.gif
1.5
Lipase (U/L)
451 https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figu_HTML.gif https://static-content.springer.com/image/art%3A10.1186%2Fs12879-021-06195-4/MediaObjects/12879_2021_6195_Figv_HTML.gif
44
   

Discussion and conclusions

C. sakazakii, previously called Enterobacter sakazakii, has been notorious since the 1980s for its fatal complications, including meningitis, hydrocephalus, and brain abscess in the neonatal population [1, 2]. C. sakazakii infections, including urinary tract infections, bacteremia, osteomyelitis, splenic abscess, and wound infections, have been reported in the adult population, particularly in those with immunocompromising conditions [37]. A clinical study on stroke patients associated it with aspiration pneumonia as higher oral C. sakazakii inoculums were reported in patient cohorts [8].
C. sakazakii has been reported in the human gastrointestinal tract, domestic and nosocomial settings, laboratory samples, and food items [913]. Bacterial contamination of infant formula milk was thought accountable for outbreaks in the neonatal population [1419]. Studies have been done and are in the process of establishing the true etiology and source of C. sakazakii, which previously had been a diagnostic challenge leading to lesser reporting [20].
The case presented is the first case of cholangitis secondary to C. sakazakii in humans. There was no radiographic evidence of cholecystitis. The source of this Gram-negative rod invasion could be from the patient’s gastrointestinal flora. Basal cell carcinoma, liver cirrhosis, advanced age, and being on long-term steroid maintenance therapy could have contributed to immunosuppression and exponential growth of the opportunistic pathogen in the colon. Studies have reported C. sakazakii in pig gallbladder, hinting towards the gallbladder being a potential site of colonization and the risk of contracting C. sakazakii from consuming pork meat [21]. We could not rule out a dietary source in this patient. Sample contamination or infection with opportunistic gastrointestinal pathogens including Klebsiella, Acinetobacter, and E. coli were ruled out as C. sakazakii with similar antibiotic sensitivity was found on PCR studies for both blood biliary fluid. Besides, there was a dramatic response to optimum antibiotic treatment.
Carbapenems have been particularly efficient as C. sakazakii is resistant to ampicillin and the majority of cephalosporins [22]. Resistance to ampicillin was reported on antibiotic susceptibility testing for this organism as well. Ceftazidime, cephalothin, and cefotaxime were not added to the antibiotic sensitivity panel, which is a shortcoming in this case. The case raises the fact that C. sakazakii is a potential causative organism for gallbladder infections, particularly in elderly populations with underlying comorbidities. In conclusion, this case is significant in its clinical manifestation, causative pathogen, infection site, and treatment.

Acknowledgments

Clinical Research Programs SIUH is acknowledged for ethical review for the use of patient data.

Declarations

The case report and manuscript were reviewed with Research Department and Ethics Committee. No experimental intervention was performed, and any specification of guidelines, legislations, or permissions were not required.
The patient and family were contacted during the hospital stay and after discharge. Written consent was obtained to use patient data, images, and blood work to publish the case for purely educational and research purposes, to which the patient and family agreed. Non identifying information usage was explained. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Competing interests

No competing financial or personal interests are involved for all the authors.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
7.
Zurück zum Zitat Dennison SK, Morris J. Multiresistant Enterobacter sakazakii wound infection in an adult. Infect Med. 2002;19:533–5. Dennison SK, Morris J. Multiresistant Enterobacter sakazakii wound infection in an adult. Infect Med. 2002;19:533–5.
15.
Zurück zum Zitat From the Centers for Disease Control and Prevention. Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001. Jama. 2002;287(17):2204–5.CrossRef From the Centers for Disease Control and Prevention. Enterobacter sakazakii infections associated with the use of powdered infant formula--Tennessee, 2001. Jama. 2002;287(17):2204–5.CrossRef
21.
22.
Zurück zum Zitat Holý O, et al. Molecular characterization of cronobacter sakazakii strains isolated from powdered milk. Foods. 2020;10(1):20.CrossRef Holý O, et al. Molecular characterization of cronobacter sakazakii strains isolated from powdered milk. Foods. 2020;10(1):20.CrossRef
Metadaten
Titel
First case report of acute cholangitis secondary to Cronobacter sakazakii
verfasst von
Syeda Sahra
Abdullah Jahangir
Neville Mobarakai
Allison Glaser
Ahmad Jahangir
Muhammad Ans Sharif
Publikationsdatum
01.12.2021
Verlag
BioMed Central
Erschienen in
BMC Infectious Diseases / Ausgabe 1/2021
Elektronische ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-021-06195-4

Weitere Artikel der Ausgabe 1/2021

BMC Infectious Diseases 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.